Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae

Shigeki Nakamura1, Kimberly M Davis, Jeffrey N Weiser

  • 1Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6076, USA.

Insights

Coinfection with influenza and pneumococcus synergistically boosts type I interferons (IFNs), impairing macrophage recruitment and increasing bacterial colonization. This IFN response hinders chemokine CCL2 production, crucial for clearing pneumococcal infections.

Area of Science:

  • Immunology
  • Microbiology
  • Respiratory Infections

Background:

  • Pneumococcal infections frequently follow influenza, contributing significantly to respiratory illness severity and mortality.
  • Understanding the interplay between influenza and pneumococcal infections is critical for public health.

Purpose of the Study:

  • To investigate the immunological mechanisms underlying enhanced pneumococcal colonization during concurrent influenza virus infection.
  • To elucidate the role of type I interferons (IFNs) and chemokine signaling in coinfection outcomes.

Main Methods:

  • Coinfection models in mice using influenza virus and Streptococcus pneumoniae.
  • Analysis of type I IFN responses, chemokine production (CCL2), and macrophage recruitment.
  • Assessment of bacterial colonization and susceptibility to invasive infection in genetically modified mice (Nod2, type I IFN receptor deficient) and with modified bacteria (pneumolysin deficient).

Main Results:

  • Concurrent influenza infection synergistically enhanced type I IFN production induced by pneumococcal colonization.
  • This synergistic IFN response led to increased pneumococcal colonization and susceptibility to invasive disease.
  • The elevated type I IFN response suppressed the production of chemokine CCL2, impairing macrophage recruitment and bacterial clearance.
  • Nod2 and pneumolysin were identified as key mediators in the pneumococcus-induced CCL2 production, and their absence or blockade of the type I IFN receptor prevented enhanced colonization.

Conclusions:

  • Synergistic type I IFN stimulation during coinfection impairs host defense by reducing CCL2-mediated macrophage recruitment.
  • This mechanism contributes to increased bacterial load and disease severity in coinfected individuals.
  • Targeting type I IFN pathways or enhancing chemokine signaling could be potential therapeutic strategies.

Related Concept Videos

The Colonization of Land02:22

The Colonization of Land

Changes in the environment of the early Earth drove the evolution of organisms. As prokaryotic organisms in the oceans began to photosynthesize, they produced oxygen. Eventually, oxygen saturated the oceans and entered the air, resulting in an increase in atmospheric oxygen concentration, known as the oxygen revolution approximately 2.3 billion years ago. Therefore, organisms that could use oxygen for cellular respiration had an advantage. More than 1.5 years ago, eukaryotic cells and...
37.6K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.8K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

No description available
3.9K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
882
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.9K
What are Viruses?00:50

What are Viruses?

Overview
128.1K